COMP <GO>
KRT vs TMO // ENTERPRISE SCALE & MARKET CAP
Karat Packaging Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: KRT 7
— TMO 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $54.39 (+1.85%) • MKT CAP: $1.08B
market-cap
$1.08B
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRT VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRT | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.30% | 9.30% | +20.00 | KRT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.9x | 30.4x | -5.50 | KRT | /valuation <GO> |
| Free Cash Flow Yield | 3.05% | 2.40% | +0.65 | KRT | /fcf-yield <GO> |
| Operating Margin | 8.90% | 17.40% | -8.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 15.10% | -8.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 10.70% | 3.90% | +6.80 | KRT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.33% | 0.24% | +3.09 | KRT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.75 | 4.50 | +3.25 | KRT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 62.9 | -7.95 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 36.3x | -4.30 | KRT | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.08B | $262.22B | -$261.13B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRT REV | TMO REV | KRT GROSS % | TMO GROSS % | KRT FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $467.7M | $44.56B | 36.8% | — | $33.1M | $6.29B |
| FY 2024 | $422.6M | $42.88B | 38.9% | — | $47.0M | $7.27B |
| FY 2023 | $405.7M | $42.86B | — | — | $53.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRT // BETA —
TMO // BETA 0.94